CELLECTIS S.A.

In News

Cellectis S.A. Updates Patent License Agreement with University of Minnesota - TipRanks

TipRanks - Dec 05, 2025

Cellectis (NASDAQ:CLLS) Stock Passes Above Fifty Day Moving Average - Should You Sell? - MarketBeat

MarketBeat - Dec 04, 2025

AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology - Reuters

Reuters - Sep 26, 2025

Earnings To Watch: Cellectis SA (CLLS) Reports Q2 2025 Result - Yahoo Finance

Yahoo Finance - Aug 04, 2025

Why Cellectis Stock Is Trading Higher Today - Cellectis (NASDAQ:CLLS) - Benzinga

Benzinga - Nov 19, 2025

Cellectis Publishes Nature Communications Article on a - GlobeNewswire

GlobeNewswire - Nov 19, 2025

AstraZeneca, Cellectis Sued Over $2.2 Billion Cancer-Drug Deal - Bloomberg Law News

Bloomberg Law News - Sep 26, 2025

Cellectis: Partnerships And Promised Data In 2025 Continue To Justify The Buy (CLLS) - Seeking Alpha

Seeking Alpha - May 15, 2025

What drives Cellectis SA Common Stock ZVAA stock price - Stock Buyback Announcements & Outstanding Capital Returns - earlytimes.in

earlytimes.in - Dec 06, 2025

Factor Bioscience Files Complaint Against Cellectis and AstraZeneca Alleging Infringement of Foundational Gene-Editing Patents - PR Newswire

PR Newswire - Sep 26, 2025

Cellectis SA expected to post a loss of 23 cents a share - Earnings Preview - TradingView

TradingView - Nov 05, 2025

High HSPC gene insertion from CssDNA; Cellectis presents non-viral template & TALEB off-target data at ESGCT - Stock Titan

Stock Titan - Oct 07, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment